Platelet Parameters—First Induction
. | Group A . | Group B . | Placebo . |
---|---|---|---|
No. of patients | 48 | 26 | 34 |
Median peak platelet count (×109/L) | 1,084 | 517 | 390 |
Range | 33-3,745 | 25-1,390 | 18-1,514 |
Median time to peak platelet count after last dose (days) | 9 | 20 | 13 |
Range | 0-15 | 0-25 | 0-28 |
Median time to peak platelet count after start of chemotherapy (days) | 29 | 27 | 28 |
Range | 12-37 | 8-38 | 10-52 |
Percentage of patients with platelet count >1,000 × 109/L | 52% | 8% | 9% |
Median days to transfusion-independent platelet recovery >20 × 109/L | 21 | 20.5 | 21 |
Range | 13-43 | 14-32 | 12-36 |
. | Group A . | Group B . | Placebo . |
---|---|---|---|
No. of patients | 48 | 26 | 34 |
Median peak platelet count (×109/L) | 1,084 | 517 | 390 |
Range | 33-3,745 | 25-1,390 | 18-1,514 |
Median time to peak platelet count after last dose (days) | 9 | 20 | 13 |
Range | 0-15 | 0-25 | 0-28 |
Median time to peak platelet count after start of chemotherapy (days) | 29 | 27 | 28 |
Range | 12-37 | 8-38 | 10-52 |
Percentage of patients with platelet count >1,000 × 109/L | 52% | 8% | 9% |
Median days to transfusion-independent platelet recovery >20 × 109/L | 21 | 20.5 | 21 |
Range | 13-43 | 14-32 | 12-36 |